351
Views
8
CrossRef citations to date
0
Altmetric
Review

Recent advancements in tension-type headache: a narrative review

ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 793-803 | Received 01 Apr 2021, Accepted 11 Jun 2021, Published online: 02 Jul 2021

References

  • Scripter C. Headache: tension-type headache. FP Essent. 2018;473:17–20.
  • Bendtsen L, Jensen R. Tension-type headache. Neurol Clin. 2009 May;27(2):525–535.
  • GBD 2016. Headache collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018 Nov;1711:954–976.
  • Headache classification subcommittee of the international headache society, the international classification of headache disorders 3rd (ICHD-3). Cephalalgia. 2013 Jul;33(9):629–808.
  • Speciali JG, Eckeli AL, Dach F, et al. Tension-type headache. Expert Rev Neurother. 2008 May;8(5):839–853.
  • Jensen RH. Tension-type headache - the normal and most prevalent headache. Headache. 2018 Feb;58(2):339–345.
  • Luciani M, Negro A, Spuntarelli V, et al. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021 Mar;21(3):277–285.
  • Bendtsen L, Fumal A, Schoenen J, et al. Tension-type headache: mechanisms. Handb Clin Neurol. 2010;97:359–366.
  • Ashina S, Bentivegna E, Martelletti P, et al. Structural and functional brain changes in Migraine. Pain Ther. 2021 Jun;10(1):211–223.
  • Skorobogatykh K, van Hoogstraten WS, Degan D, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Functional connectivity studies in migraine: what have we learned? J Headache Pain. 2019 Nov 20;20(1):108.
  • Straube A, Andreou A. Primary headaches during lifespan. J Headache Pain. 2019;20(1):35.
  • Bendtsen L, Ashina S, Moore A, et al. Muscles and their role in episodic tension-type headache: implications for treatment. Eur J Pain. 2016 Feb;20(2):166–175.
  • Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain. 1993 Sep;54(3):241–289.
  • Mense S. Algesic agents exciting muscle nociceptors. Exp Brain Res. 2009 Jun;196(1):89–100.
  • Cook SP, McCleskey EW. Cell damage excites nociceptors through release of cytosolic ATP. Pain. 2002;95(1):41–47.
  • Babenko V, Graven-Nielsen T, Svensson P, et al. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain. 1999 Jul;82(1):1–8.
  • Mørk H, Ashina M, Bendtsen L, et al. Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur J Pain. 2003;7(2):145–153.
  • Dawson A, Stensson N, Ghafouri B, et al. in plasma - a biomarker for myofascial TMD pain? J Headache Pain. 2016 Dec;17(1):65.
  • Korotkova M, Lundberg IE. The skeletal muscle arachidonic acid cascade in health and inflammatory disease. Nat Rev Rheumatol. 2014;10(5):295–303.
  • Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci. 2008 Dec 24;28(52):14062–14073.
  • Schaible HG, von Banchet GS, Boettger MK, et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci. 2010 Apr;1193(1):60–69.
  • Ohtori S, Takahashi K, Moriya H. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine (Phila Pa 1976). 2004;29(10):1082–1088.
  • Samad TA, Wang H, Broom DC. Central neuroimmune interactions after peripheral inflammation: interleukin1-b potentiates synaptic transmission in the spinal cord. Proc Soc Neurosci. 2004;34:511–517.
  • Hucho T, Levine JD. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron. 2007;55(3):365–376.
  • Edwards RR, Kronfli T, Haythornthwaite JA. Association of catastrophizing with interleukin-6 responses to acute pain. Pain. 2008;140(1):135–144.
  • Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6(7):521–532.
  • Della Vedova C, Cathcart S, Dohnalek A, et al. Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients. Pain Res Manag. 2013;18(6):301–306.
  • Domingues RB, Duarte H, Rocha NP. Increased serum levels of interleukin-8 in patients with tension-type headache. Cephalalgia. 2015 Aug;35(9):801–806.
  • Koçer A, Koçer E, Memişoğullari R. Interleukin-6 levels in tension headache patients. Clin J Pain. 2010 Oct;26(8):690–693.
  • Bougea A, Spantideas N, Galanis P. Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study. Neurol Sci. 2020 Apr;41(4):877–884.
  • Do TP, Heldarskard GF, Kolding LT, et al. Myofascial trigger points in migraine and tension-type headache. J Headache Pain. 2018;19(1):84.
  • Fernández-de-Las-Peñas C, Cuadrado ML, Arendt-Nielsen L, et al. Increased pericranial tenderness, decreased pressure pain threshold, and headache clinical parameters in chronic tension-type headache patients. Clin J Pain. 2007 May;23(4):346–352.
  • Sakai F, Ebihara S, Akiyama M, et al. Pericranial muscle hardness in tension-type headache. A non-invasive measurement method and its clinical application. Brain. 1995 Apr;118(2):523–531.
  • Ashina M, Bendtsen L, Jensen R, et al. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain. 1999 Feb;79(2):201–205.
  • Gerwin RD, Dommerholt J, Shah JP, et al. An expansion of Simons’ integrated hypothesis of trigger point formation. Curr Pain Headache Rep. 2004;8(6):468–475.
  • Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008 Jan;89(1):16–23.
  • Nöbel M, Feistel S. ATP-sensitive muscle afferents activate spinal trigeminal neurons with meningeal afferent input in rat – pathophysiological implications for tension-type headache. J Headache Pain. 2016;17(1):75.
  • Fernández-de-las-Peñas C, Fernández-Mayoralas DM, Ortega-Santiago R, et al. Referred pain from myofascial trigger points in head and neck- shoulder muscles reproduces head pain features in children with chronic tension type headache. J Headache Pain. 2011;12(1):35–43.
  • Romero-Morales C, Jaén-Crespo G, Rodríguez-Sanz D, et al. Comparison of pressure pain thresholds in upper trapezius and temporalis muscles trigger points between tension type headache and healthy participants: a case-control study. J Manip Physiol Ther. 2017;40(8):609–614.
  • Russell MB. Genetics of tension-type headache. J Headache Pain. 2007 Apr;8(2):71–76.
  • Russell MB, Ostergaard S, Bendtsen L, et al. Familial occurrence of chronic tension-type headache. Cephalalgia. 1999 May;19(4):207–210.
  • Russell M, Iselius L, Østergaard S, et al. Inheritance of chronic tension-type headache investigated by complex segregation analysis. Hum Genet. 1998;102(2):138–140.
  • Ulrich V, Gervil M, Olesen J, et al. The relative influence of environment and genes in episodic tension-type headache. Neurology. 2004 Jun 8;62(11):2065–2069.
  • Russell MB, Saltyte-Benth J, Levi N, et al. Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J Headache Pain. 2006 Jun;7(3):119–126.
  • An XK, Lu CX, Ma QL, et al. Association of MTHFR C677T polymorphism with susceptibility to migraine in the Chinese population. Neurosci Lett. 2013 Aug 9;549:78–81.
  • Samaan Z, Gaysina D, Cohen-Woods S, et al. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol. 2011 Jun 2;11(1):66.
  • Miao J, Wang F, Zheng W, et al. Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis. BMC Neurol. 2015 Aug;12(15):138.
  • Kowalska M, Prendecki M, Kapelusiak-Pielok M, et al. Analysis of genetic variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a possible marker of migraine. Curr Genomics. 2020 Apr;21(3):224–236.
  • Yakubova A, Davidyuk Y, Tohka J, et al. Searching for predictors of migraine chronification: a pilot study of 1911A>G Polymorphism of TRPV1 gene in episodic versus chronic migraine. J Mol Neurosci. 2021 Mar;71(3):618–624.
  • Carreño O, Corominas R, Fernández-Morales J, et al. SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(1(Jan):94–103.
  • Moreno-Mayordomo R, Ruiz M, Pascual J, et al. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with onabotulinumtoxin A. J Headache Pain. 2019 Apr 23;20(1):39.
  • Rainero I, Rubino E, Paemeleire K, et al. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain. 2013;14(1):61.
  • Duko B, Ayalew M, Toma A, et al. The epidemiology of headaches among patients with epilepsy: a systematic review and meta-analysis. J Headache Pain. 2020;21(1):3.
  • Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache. 2006;46(9):1344–1363.
  • Houle TT, Butschek RA, Turner DP, et al. Stress and sleep duration predict headache severity in chronic headache sufferers. Pain. 2012 Dec;153(12):2432–2440.
  • Kim J, Cho SJ, Kim WJ, et al. Excessive daytime sleepiness is associated with an exacerbation of migraine: a population-based study. J Headache Pain. 2016 Dec;17(1):62.
  • Engstrøm M, Hagen K, Bjørk MH, et al. Sleep quality and arousal in migraine and tension-type headache: the headache-sleep study. Acta Neurol Scand Suppl. 2014;129(198):47–54.
  • Skogvold L, Magnussen LH. Chronic tension-type headache and coping strategies in adolescents: a qualitative interview study. Physiother Res Int. 2019 Jul;24(3):e1778.
  • Haque B, Rahman KM, Hoque A, et al. Precipitating and relieving factors of migraine versus tension type headache. BMC Neurol. 2012 Aug;25(12):82.
  • Cho S-J, Song T-J, Chu MK, et al. Sleep and tension-type headache. Curr Neurol Neurosci Rep. 2019;19(7):44.
  • Holland PR, Holland PR. Et al. Headache and sleep: shared pathophysiological mechanisms. Cephalalgia. 2014 Sep;34(10):725–744.
  • Rains JC, Davis RE, Smitherman TA, et al. Tension-type headache and sleep. Curr Neurol Neurosci Rep. 2015;15(2):520.
  • Thorn BE, Clements KL, Ward LC, et al. Personality factors in the explanation of sex differences in pain catastrophizing and response to experimental pain. Clin J Pain. 2004 Sep-Oct;20(5):275–282.
  • Marcus DA. Sex hormones and chronic headache in women. Expert Opin Pharmacother. 2001 Nov;2(11):1839–1848.
  • Alashqar A, Shuaibi S, Ahmed SF, et al. Impact of Puberty in girls on prevalence of primary headache disorder among female schoolchildren in Kuwait. Front Neurol. 2020;11:594.
  • Philipp J, Zeiler M, Wöber C, et al. Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18 years. J Headache Pain. 2019 Nov 6;20(1):101.
  • Karlı N, Baykan B, Ertaş M, et al. Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain. 2012;13(7):557–565.
  • Freeman EW, Sammel MD, Lin H, et al. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol. 2008 Jan;111(1):127–136.
  • Delaruelle Z, Ivanova TA, Khan S, et al. Male and female sex hormones in primary headaches. J Headache Pain. 2018;19(1):117.
  • Oh K, Jung KY, Choi JY, et al. Headaches in middle-aged women during menopausal transition: a headache clinic-based study. Eur Neurol. 2012;68(2):79–83.
  • Fillingim RB, King CD, Ribeiro-Dasilva MC et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009 May;10(5):447–485.
  • Cigarán-Méndez M, Jiménez-Antona C, Parás-Bravo P, et al. Active trigger points are associated with anxiety and widespread pressure pain sensitivity in women, but not men, with tension type headache. Pain Pract. 2019 Jun;19(5):522–529.
  • Waldie KE, Thompson JM, Mia Y, et al. Risk factors for migraine and tension-type headache in 11 year old children. J Headache Pain. 2014;15(1):60.
  • Arruda MA, Guidetti V, Galli F, et al. Prenatal exposure to tobacco and alcohol are associated with chronic daily headaches at childhood: a population based study. Arq Neuropsiquiatr. 2011;69(1):27–33.
  • Talge N, Neal C, Glover V, et al. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry. 2007;48(3–4):245–261.
  • Hershey DA, Winner P, Marielle A, et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache. 2005;45(10):1288–1297.
  • Fekkes M, Pijpers FIM, Verleoove-Vanhorick SP, et al. Bullying behavior and associations with psychosomatic complaints and depression in victims. J Paediatr. 2004;144(1):17–22.
  • Metsahonkala L, Sillanpaa M, Tuominen J, et al. Social environment and headache in 8–9-year-old children: a follow-up study. Headache. 1998;38(3):222–228.
  • Williams K, Chambers M, Logan S, et al. Association of common health symptoms with bullying in primary school children. BMJ. 1996;313(7048):17–19.
  • Pogliani L, Spiri D, Penagini F, et al. Headache in children and adolescents aged 6–18 years in northern Italy: prevalence and risk factors. Eur J Paediatr Neurol. 2011;15(3):234–240.
  • Mazzone L, Vitiello B, Incorpora G, et al. Behavioural and temperamental characteristics of children and adolescents suffering from primary headache. Cephalalgia. 2005;26(2):194–201.
  • Schramm. Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain. 14(1): 40. 2013.
  • Cathcart S, Petkov J, Winefield AH, et al. Central mechanisms of stress-induced headache. Cephalalgia. 2009 July 10;30(3):285–295.
  • Palacios-Ceña M, Fernández-Muñoz JJ, Castaldo M, et al. The association of headache frequency with pain interference and the burden of disease is mediated by depression and sleep quality, but not anxiety, in chronic tension type headache. J Headache Pain. 2017 Dec;18(1):19.
  • Bendtsen L. César Fernández-de-la-Peñas et al. Curr Pain Headache Rep. 2011;15(6):451–458.
  • Chatchawan U, Thongbuang S, Yamauchi J, et al. Characteristics and distributions of myofascial trigger points in individuals with chronic tension-type headaches. J Phys Ther Sci. 2019 Apr;31(4):306–309.
  • Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742–746.
  • Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol. 2007;20(3):326–330.
  • Bendtsen L, Evers S, Linde M, et al., Searching for predictors of migraine chronification: a pilot study of 1911A>G polymorphism of TRPV1 gene in episodic versus chronic migraine. Eur J Neurol. 17(3): 1318. 2010.
  • Lenaerts ME. Pharmacotherapy of tension-type headache (TTH). Expert Opin Pharmacother. 2009;10(8):1261.
  • Verhagen AP, Damen L, Berger MY, et al. [Treatment of tension type headache: paracetamol and NSAIDs work: a systematic review]. Ned Tijdschr Geneeskd. 2010;154:A1924.
  • Stephens G, Derry S, Moore RA. Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2016;6:CD011889. DOI:10.1002/14651858.CD011889.pub2
  • Derry S, Wiffen PJ, Moore RA, et al. Ibuprofen for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 201531(7):CD011474. PMID:2623487.
  • Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia. 2003;23(1):59.
  • Prior MJ, Cooper KM, May LG, et al. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002;22(9):740.
  • Tagliente F, Ruju FM, Pascotto A. Treatment of episodic and chronic tension-type headache in children and adolescents. J Headache Pain. 2004;5(S2):s59–s61.
  • Derry S, Wiffen PJ, Moore RA. Aspirin for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2017;1:CD011888.
  • von Graffenried B, Nüesch E. Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol. 1980;10(Suppl 2):225S.
  • Langemark M, Olesen J. Effervescent ASA versus solid ASA in the treatment of tension headache. A double-blind, placebo controlled study. Headache. 1987;27(2):90–95.
  • Farinelli I, Martelletti P. Aspirin and tension-type headache. J Headache Pain. 2007;8(1):49–55.
  • Mathew N, Ashina M. Acute pharmacotherapy of tension-type headaches. In: Olesen J, Goadsby PJ, Ramadan N, et al.editors. The Headaches. Philadelphia: Lippincott Williams Wilkins; 2015. p. 727–733.
  • Ashina S, Ashina M, et al. Current and potential future drug therapies for tension-type headache. Curr Pain Headache Rep. 2003;7(6):466–474.
  • Schachtel BP, Furey SA, Thoden WR. Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache. J Clin Pharmacol. 1996;36(12):1120.
  • Packman B, Packman E, Doyle G, et al. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache. 2000;40(7):561.
  • Mehlisch DR, Weaver M, Fladung B. Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache. 1998;38(8):579.
  • Dahlöf CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia. 1996;16(2):117.
  • Miller DS, Talbot CA, Simpson W, et al. A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache. 1987;27(7):392.
  • Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia. 1998;18(1):38.
  • Martínez-Martín P, Raffaelli E, Titus F, et al. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia. 2001;21(5):604.
  • Lange R, Lentz R. Comparison ketoprofen, ibuprofen and naproxen sodium in the treatment of tension-type headache. Drugs Exp Clin Res. 1995;21(3):89.
  • Diamond S. Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache. 1983;23(5):206.
  • van Gerven JM, Schoemaker RC, Jacobs LD, et al. Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol. 1996;42(4):475.
  • Kubitzek F, Ziegler G, Gold MS, et al. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain. 2003;7(2):155.
  • Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483.
  • Lipton RB, Diener HC, Robbins MS, et al. Caffeine in the management of patients with headache. J Headache Pain. 2017;18(1):107.
  • Diamond S, Freitag FG. The use of ibuprofen plus caffeine to treat tension-type headache. Curr Pain Headache Rep. 2001;5(5):472.
  • Migliardi JR, Armellino JJ, Friedman M, et al. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther. 1994;56(5):576.
  • Diamond S. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther. 2000;68(3):312–319.
  • Pini LA, Del Bene E, Zanchin G, et al. Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium. J Headache Pain. 2008;9(6):367–373.
  • Scher AI, Lipton RB, Stewart WF, et al. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia. 2010;30(3):321-328.
  • Brennum J, Brinck T, Schriver L, et al. Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol. 1996;3(1):23–28.
  • Dowson AJ, Tepper SJ, Baos V, et al. Identifying patients who require a change in their current acute migraine treatment: the migraine assessment of current therapy (migraine-ACT) questionnaire. Curr Med Res Opin. 2004;20(7):1125.
  • ”The International Headache Classification”. ihs-classification.org. International Headache Society. Archived from the original on 4 March 2016 Retrieved 2014 Jun 28.
  • Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004 Dec 14;63(11):2022–2027.
  • Management of medication overuse headache. BMJ. 2010 Apr 28;340:c1305.
  • Chiang CC, Schwedt TJ, Wang SJ, et al. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2016 Apr;36(4):371–386.
  • de Filippis S, Salvatori E, Farinelli I, et al. Chronic daily headache and medication overuse headache: clinical read-outs and rehabilitation procedures. Clin Ter. 2007 Jul-Aug;158(4):343–347.
  • Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006 Jun 27;66(12):1894–1898.
  • Martelletti P, Luciani M, Spuntarelli V, et al. Deprescribing in migraine. Expert Opin Drug Saf. 2021 Mar 25:1–3.
  • Ertsey C, Magyar M, Gyüre T, et al. Tension type headache and its treatment possibilities. Ideggyogy Sz. 2019 Jan 30;72(1–2):13–21.
  • Jackson JL, Mancuso JM, Nickoloff S. Tricyclic and tetracyclic antidepressants for the prevention of frequent episodic or chronic tension-type headache in adults: a systematic review and meta-analysis. J Gen Intern Med. 2017;32(12):1351–1358.
  • Gorenstein C, Andrade L, Moreno RA. Social adjustment in depressed patients treated with venlafaxine and amitriptyline. Int Clin Psychopharmacol. 2002;17(4):171–175.
  • Palacios-Ceña M, Wang K, Castaldo M, et al. Variables associated with the use of prophylactic amitriptyline treatment in patients with tension-type headache. Clin J Pain. 2019 Apr;35(4):315–320.
  • Zissis N, Harmoussi S, Vlaikidis N, et al. A randomized,double-blind, placebo-controlled study of venlafaxineXR in out-patients with tension-type headache. Cephalalgia. 2007;27(4):315–324.
  • Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology. 2004 May;62(10):1706–1711.
  • Lampl C, Marecek S, May A, et al. A prospective,open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia. 2006;26(10):1203–1208.
  • Smuts JA, Baker MK. Prophylactic treatment of chronic tension‐type headache using botulinum toxin type. Eur J Neurol. 1999;6(Suppl):4).
  • Prakash S, Shah ND. Chronic tension-type headache with vitamin D deficiency: casual or causal association? Headache. 2009 Sep 8;49(8):1214–1222.
  • Prakash S, Mehta NC, Dabhi AS, et al. The prevalence of headache may be related with the latitude: a possible role of Vitamin D insufficiency? J Headache Pain. 2010 Aug;11(4):301–307.
  • Nowaczewska M, Wiciński M, Osiński S, et al. the role of vitamin d in primary headache–from potential mechanism to treatment. Nutrients. 2020 Jan 17;12(1):243.
  • Durazzo TC. Comparison of regional brain perfusion levels in chronically smoking and non-smoking adults. Int J Environ Res Public Health. 2015;12(7):8198.
  • Krøll LS, Hammarlund CS. The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial. Cephalalgia. 2018 October;38(12):1805–1816.
  • Shhiller J, Karst M, Kellner T, et al. Combination of acupuncture and medical training therapy on tension type headache: results of a randomised controlled pilot study. Cephalalgia. 202141(8):879–893.
  • Hammill JM, Cook TM and Rosecrance JC. Effectiveness of a physical therapy regimen in the treatment of tension type headache. Headache. 1996;36(3):149–153.
  • Gil Martinez A, Kindelan P, Agudo-Carmona D, et al. Therapeutic exercise as treatment for migraine and tension-type headaches: a systematic review of randomized clinical trials. Rev Neurol. 2013;57(10):433–443.
  • Torelli P, Jensen R and Olesen J. Physiotherapy for tension-type headache: a controlled study. Cephalalgia. 2004;24(1):29–36.
  • Scharrer M, Ebenbichler G, Pieber K, et al. A systematic review on the effectiveness of medical training therapy for subacute and chronic low back pain. Eur J Phys Rehabil Med. 2012;48(3):361–371.
  • Rice D, Nijs J, Kosek E, et al. Exercise-induced hypoalgesia pain-free and chronic pain populations: state of the art and future directions. J Pain. 2019;20(11):1249–1266.
  • Nugraha B, Karst M, Engeli S, et al. Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review. Rheumatol Int. 2011;32(9):2593–2599.
  • Fredholm BB. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83–133.
  • Bendtsen L. Central sensitization in tension-type headache - possible pathophysiological mechanisms. Cephalalgia. 2000;20(5):486–508.
  • Gulotta, et al. P031. An observational study on chronic tension-type headache treatment with quantum molecular resonance according to I.A.R.A. model. J Headache Pain. 2015;16(Suppl1):A176.
  • Jensen R, Bentsen L, Olesen J. Muscular factors are of importence in tension-type headache. Headache. 1998;38(1):10–17.
  • Nestoriuc Y, Rief W, Martin A. Meta-analysis of bio-feedback for tension-type headache: efficacy, specificity and treatment moderators. J Consult Clin Psychol. 2008;76(3):379–396.
  • Ezra. EHMTI-0395. Hypnotic relaxation vs amitriptyline for tension-type headache: let the patient choose. J Headache Pain. 2014;15(Suppl1):I3.
  • Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523–1537.
  • Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11:CD007407.
  • Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;1:CD001117.
  • Deakin T, McShane CE, Cade JE, et al. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2:CD003417.
  • Linde K, Allais G, Brinkhaus B, et al. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009;CD007587.
  • Hao X, Shi Y. Evaluating influential factors of acupuncture for tension-type headache. Medicine (Baltimore). 2020 November 13;99(46):e23118.
  • Moraska AF, Stenerson L. Myofascial trigger point-focused head and neck massage for recurrent tension-type headache: a randomized, placebo-controlled clinical trial. Clin J Pain. 2015 Feb;31(2):159–168.
  • Schoenen J. Tension-type headache and fibromyalgia: what’s common, what’s different? Neurol Sci. 2004 Oct;25(Suppl 3):S157–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.